logo
Products
Services
Resources
Selection Guides
About
iFluor® 555 Anti-human CD21 Antibody
HI21a
The HI21a monoclonal antibody recognizes human CD21, a 145 kD transmembrane glycoprotein frequently expressed on the surface of thymocytes and dendritic cells. CD21 plays a role in vital cellular pathways, namely, the complement activation, classical pathway. In addition, it has been associated with vital biological processes like immune response, specifically innate immune response. From a research standpoint, it is of biological interest due to its association with essential macromolecules/ligands such as CD19, CD23 and C3d. CD21 is a fairly uncommon antibody target, with a little more than 5000 publications in the last decade. Even still, CD21 is essential for complement, innate immunity and immunology research, often serving as a phenotypic marker for differentiating cell types in flow cytometric applications. This antibody was purified through affinity chromatography and conjugated to iFluor® 555 (ex/em = 557/570 nm). It is compatible with the 561 nm laser and 577/35 nm bandpass filter (for example, as in the Luminex Amnis FlowSight).
product image
CatalogSize
Price
Quantity
10210090100 tests
Price
10210091500 tests
Price
 
Physical properties

Molecular weightN/A
Solventwater
Antibody properties

Other namesCR2, C3dR, Epstein-Barr virus receptor
CloneHI21a
HostMouse
IsotypeIgG2a
ReactivityHuman
ApplicationFlow Cytometry (FACS), Fluorescence Imaging
Spectral properties

Correction factor (260 nm)0.23
Correction factor (280 nm)0.14
Extinction coefficient (cm -1 M -1)
100000
1
Excitation (nm)557
Emission (nm)570
Quantum yield
0.64
1
Usage and storage

Intended useResearch Use Only (RUO)
StorageRefrigerated (2-8 °C); Minimize light exposure
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on August 5, 2026